MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Clinical trials for MODERATE TO SEVERE RHEUMATOID ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE RHEUMATOID ARTHRITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE RHEUMATOID ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug afimkibart tested for Long-Term arthritis control
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of a drug called afimkibart in people with moderate to severe rheumatoid arthritis. Participants have already taken afimkibart in a previous study and will continue taking it. The goal is to see if the drug remains safe…
Matched conditions: MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Which RA drug keeps patients on board longer? new study aims to find out
Disease control Recruiting nowThis study tracks about 678 adults with moderate to severe rheumatoid arthritis in Germany to see how long they stay on either upadacitinib or TNF inhibitors. Doctors choose the treatment before the study starts, based on standard care. The goal is to learn which drug people stic…
Matched conditions: MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC